Sareum Holdings plc (LON:SAR – Get Free Report)’s share price crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of GBX 36.72 ($0.47) and traded as low as GBX 29 ($0.37). Sareum shares last traded at GBX 29 ($0.37), with a volume of 369,295 shares.
Sareum Price Performance
The firm has a 50-day simple moving average of GBX 36.72 and a 200 day simple moving average of GBX 32.45. The company has a market capitalization of £30.23 million, a PE ratio of -483.33 and a beta of -1.03.
Sareum Company Profile
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
See Also
- Five stocks we like better than Sareum
- What is Short Interest? How to Use It
- Uber’s Earnings Beat: Rideshare and Delivery Surge
- How to Evaluate a Stock Before Buying
- Hims & Hers Reports Stellar Quarter: Stock Set for a Rally
- The 3 Best Fintech Stocks to Buy Now
- Cloudflare Stock Flares Up on Solid EPS Beat and Raised Guidance
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.